Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It?

Pierre Olivier Lang, Pierre Loulergue, Richard Aspinall

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Chikungunya virus (CHIKV) was until recently perceived only as a tropical disease. Since the first report of a case in Saint Martin Island in 2013, it has spread to South, Central, and North America. The first local transmission in the continental United States was reported in Florida in July 2014. CHIV infection is known to cause debilitating rheumatologic disease. Older adults are particularly susceptible to severe and chronic infection. Without an effective vaccine and antiviral therapy to prevent and control CHIKV, U.S. geriatricians could soon be confronted with major clinical, functional, and therapeutic challenges. After a general overview of CHIKV infection, this review will examine reasons why it has become such a threat to the United States and consider factors that contribute to the greater burden and effect of this disease in elderly adults. Consideration will be given to how aging and immunosenescence may contribute to CHIKV's atypical and more-severe clinical features in older adults. This review concludes with possible therapeutic approaches that best fit the unique needs of older adults, especially with regard to multimorbidity and polypharmacy.

Original languageEnglish
Pages (from-to)2529-2534
Number of pages6
JournalJournal of the American Geriatrics Society
Volume65
Issue number11
Early online date21 Sep 2017
DOIs
Publication statusPublished - 1 Nov 2017
Externally publishedYes

Fingerprint

Chikungunya virus
Active Immunotherapy
Central America
Polypharmacy
South America
North America
Infection
Islands
Antiviral Agents
Comorbidity
Therapeutics
Geriatricians
Chikungunya Fever

Keywords

  • aged people
  • chikungunya virus infection
  • clinical forms

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Chikungunya Virus Infection : Why Should U.S. Geriatricians Be Aware of It? / Lang, Pierre Olivier; Loulergue, Pierre; Aspinall, Richard.

In: Journal of the American Geriatrics Society, Vol. 65, No. 11, 01.11.2017, p. 2529-2534.

Research output: Contribution to journalArticle

@article{980632da0d614454b85234fd816f3c31,
title = "Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It?",
abstract = "Chikungunya virus (CHIKV) was until recently perceived only as a tropical disease. Since the first report of a case in Saint Martin Island in 2013, it has spread to South, Central, and North America. The first local transmission in the continental United States was reported in Florida in July 2014. CHIV infection is known to cause debilitating rheumatologic disease. Older adults are particularly susceptible to severe and chronic infection. Without an effective vaccine and antiviral therapy to prevent and control CHIKV, U.S. geriatricians could soon be confronted with major clinical, functional, and therapeutic challenges. After a general overview of CHIKV infection, this review will examine reasons why it has become such a threat to the United States and consider factors that contribute to the greater burden and effect of this disease in elderly adults. Consideration will be given to how aging and immunosenescence may contribute to CHIKV's atypical and more-severe clinical features in older adults. This review concludes with possible therapeutic approaches that best fit the unique needs of older adults, especially with regard to multimorbidity and polypharmacy.",
keywords = "aged people, chikungunya virus infection, clinical forms",
author = "Lang, {Pierre Olivier} and Pierre Loulergue and Richard Aspinall",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/jgs.15104",
language = "English",
volume = "65",
pages = "2529--2534",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley",
number = "11",

}

TY - JOUR

T1 - Chikungunya Virus Infection

T2 - Why Should U.S. Geriatricians Be Aware of It?

AU - Lang, Pierre Olivier

AU - Loulergue, Pierre

AU - Aspinall, Richard

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Chikungunya virus (CHIKV) was until recently perceived only as a tropical disease. Since the first report of a case in Saint Martin Island in 2013, it has spread to South, Central, and North America. The first local transmission in the continental United States was reported in Florida in July 2014. CHIV infection is known to cause debilitating rheumatologic disease. Older adults are particularly susceptible to severe and chronic infection. Without an effective vaccine and antiviral therapy to prevent and control CHIKV, U.S. geriatricians could soon be confronted with major clinical, functional, and therapeutic challenges. After a general overview of CHIKV infection, this review will examine reasons why it has become such a threat to the United States and consider factors that contribute to the greater burden and effect of this disease in elderly adults. Consideration will be given to how aging and immunosenescence may contribute to CHIKV's atypical and more-severe clinical features in older adults. This review concludes with possible therapeutic approaches that best fit the unique needs of older adults, especially with regard to multimorbidity and polypharmacy.

AB - Chikungunya virus (CHIKV) was until recently perceived only as a tropical disease. Since the first report of a case in Saint Martin Island in 2013, it has spread to South, Central, and North America. The first local transmission in the continental United States was reported in Florida in July 2014. CHIV infection is known to cause debilitating rheumatologic disease. Older adults are particularly susceptible to severe and chronic infection. Without an effective vaccine and antiviral therapy to prevent and control CHIKV, U.S. geriatricians could soon be confronted with major clinical, functional, and therapeutic challenges. After a general overview of CHIKV infection, this review will examine reasons why it has become such a threat to the United States and consider factors that contribute to the greater burden and effect of this disease in elderly adults. Consideration will be given to how aging and immunosenescence may contribute to CHIKV's atypical and more-severe clinical features in older adults. This review concludes with possible therapeutic approaches that best fit the unique needs of older adults, especially with regard to multimorbidity and polypharmacy.

KW - aged people

KW - chikungunya virus infection

KW - clinical forms

UR - http://www.scopus.com/inward/record.url?scp=85032221067&partnerID=8YFLogxK

U2 - 10.1111/jgs.15104

DO - 10.1111/jgs.15104

M3 - Article

VL - 65

SP - 2529

EP - 2534

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 11

ER -